Abstract
CT-guided procedures remain an important tool for diagnosis and tissue acquisition for primary diagnosis and molecular/tissue correlation. New imaging devices such as MDCT and PET/CT will improve diagnosis but percutaneous procedures will be needed to confirm and support new molecular and DNA treatments. Coagulopathic patients can be treated with LIBE a new method to prevent bleeding. Vasoactive drugs can be used to improve differentiation of malignant and benign diseases.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haaga, J.R. Interventional CT: 30 years’ experience. Eur Radiol Suppl 15 (Suppl 4), d116–d120 (2005). https://doi.org/10.1007/s10406-005-0130-9
Issue Date:
DOI: https://doi.org/10.1007/s10406-005-0130-9